Established in the year 2004, Sakar is engaged in manufacturing of Pharmaceutical products providing Liquid Orals, Cephalosporin Tablet, Capsule, Dry Powder Syrup, Dry Powder Injections, Liquid Injectables (SVP) in Ampoules and Vials & Lyophilized Injections.
Sakar is managed by a team of professionals with an endeavour to offer Quality Pharmaceutical & Health Care Products in various countries. The company operates as contract development and manufacturing organisation (CDMO), being the EU GMP approved CMO for leading multinational pharmaceutical companies.
Sakar Healthcare has walked the path of brisk success because of its uncompromised values and impregnable entrepreneurial acumen. The Liquid & Lyophilised Injection unit (small volume parenterals in ampoules and vials) at Sakar Healthcare has been EU GMP approved and all four state of the art manufacturing units are certified by ISO 9001:2015 BVQI , WHO-GMP, cGMP, in addition to the approvals by ‘National Drug Authority’ of Uganda, Kenya, Yemen, Ethiopia, Congo, Ghana, Zimbabwe(MCAZ), Cambodia, Vietnam, Malawi, Namibia, Nigeria, Cote d’ivoire, Philippines, Peru.
We also cater to Srilanka, Philippines, Vietnam, Cambodia, Sudan, Myanmar, Mauritius, and Costa Rica, Panama, El-salvador, Paraguay, etc. in Latin America. Sakar Healthcare boasts some of the most modern and state-of-the-art facilities for manufacturing of various products under its head. Being approved by the WHO of more than multiple countries, these facilities not only create a vote of confidence in the products of the firm, but also improve considerably the quality that is being offered to the clients, all across the globe.
Steadily Sakar is on the path of building a sustainable pharmaceutical organization. Over these years Sakar has displayed a powerful drive for growth & advancement that are essentials for the varying circumstances in the Global Pharmaceutical Industry.
The company has got listed at National Stock Exchange (NSE), Mumbai - India.
Sakar has a visible presence across the regions of Africa (Anglo & Francophone), SEASIA, CIS, Latin & Central America and recently in Europe. Operating in over 50 countries globally, Sakar has 292 registered products and further 210 products under registration. Sakar has +70 overseas partners, who helps in promotion and distribution of Sakar brands in multiple nations.
The Research-driven API-integrated ONCOLOGY finished dosage-OSD (tablet, capsule, granule) & Injection (liquid, lyophilised) manufacturing unit has become fully operational with domestic supplies and international regulatory compliant. The manufacturing block for OSD and injection have received EU GMP approval to export oncology products to regulated markets; certification will remain valid for three years. The technical team competency , regulatory team compliances and business development team precision have help creating this milestone.
